1.Possible Roles of UL112-113 Proteins in Human Cytomegalovirus DNA Replication.
Journal of Bacteriology and Virology 2012;42(2):162-168
DNA replication of human cytomegalovirus (HCMV) is a highly regulated process that requires specific interactions between cis-acting lytic origin of replication (oriLyt) and trans-acting viral proteins. Formation of the replication initiation complex is also regulated by specific interactions among viral replication proteins. HCMV replication proteins include origin-binding proteins, core proteins that work in replication forks, and regulatory proteins that modulate host cell functions. This letter describes intriguing questions regarding how HCMV origin-binding proteins interact with oriLyt to initiate DNA replication and how the regulatory UL112-113 proteins, which are found only in beta-herpesviruses, function to promote viral DNA replication.
Cytomegalovirus
;
DNA
;
DNA Replication
;
DNA, Viral
;
Humans
;
Proteins
;
Replication Origin
;
Viral Proteins
4.Partial Nucleotide Sequence of Porcine Parvovirus (VRI-1 Strain): Identification of the Putative Defective Genomes.
Byoung Han KIM ; Soo Hwan AN ; Chang Hee KWEON ; Jae Young SONG ; Jong Hyeon PARK ; Bang Hun HYUN ; Dong Kun YANG ; Ryun Bin TAK
Journal of Bacteriology and Virology 2004;34(3):201-212
A porcine parvovirus, designated as VRI-1, was isolated from a 30-day-old piglet. Replicative form of viral DNA from ST cells infected with VRI-1 was directly cloned into pUC19. The cloned DNA fragment contained the entire nonstructural and structural protein genes, covering approximately 85% of the viral genome. The nucleotide sequence of VRI-1 showed 99.4~99.5% identity in the nonstructural protein (NS) and 99.0~99.2% identity in the structural protein with previously reported PPV strains, respectively. Among the cloned genes, two types of defective genomes with deletion of 100 and 247 nucleotides at almost similar location of 3' region within NS gene were also identified in this study.
Base Sequence*
;
Clone Cells
;
DNA
;
DNA, Viral
;
Genome*
;
Genome, Viral
;
Nucleotides
;
Parvovirus, Porcine*
5.A new member of Brevidensovirus, 0507JS11 virus isolated from Culex mosquitoes collected in Xinjiang.
Xin-jun LÜ ; You-gang ZHAI ; Xiao-hong SUN ; Shi-hong FU ; Huan-qin WANG ; Su-xiang TONG ; Song ZHANG ; Guo-dong LIANG
Chinese Journal of Preventive Medicine 2009;43(5):385-389
OBJECTIVETo probe the primary characteristic of 0507JS11 virus isolated from Culex sp. and determine the classification of 0507JS11 virus in taxonomy.
METHODS0507JS11 virus was cultured in Aedes albopictus C6/36 cells and cytopathic effects (CPEs) were recorded. Electro-microscopic morphology of 0507JS11 virus was observed. Total DNA extract of 0507JS11 virus was detected by 1% Agarose Gel Electrophoresis. Complete genomic sequence of 0507JS11 virus was sequenced and then made phylogenetic analysis.
RESULTS0507JS11 virus could cause CPEs in Aedes albopictus C6/36 cells. Viral particles have no envelope and appear icosahedron symmetry with diameter of 20 nm. The genome of 0507JS11 virus was positive single strand DNA (ssDNA) with full length of 3977 nt. However, a DNA band about 4 kbp was observed in the electrophoresis of total DNA extract of 0507JS11 virus. The coding region of the genome included three ORFs, ORF1 and ORF2 code NSP1 and NSP2, ORF3 codes VP. Phylogenetic analysis of the complete genomic sequence of 0507JS11 virus indicated an independent linear in Brevidensovirus.
CONCLUSION0507JS11 virus is a new member in Brevidensovirus.
Animals ; Culex ; virology ; DNA, Viral ; genetics ; Densovirinae ; classification ; genetics ; isolation & purification ; Genome, Viral ; Sequence Analysis, DNA
6.EBV in situ hybridization study for non-Hodgkin's lymphomas.
Journal of Korean Medical Science 1994;9(3):224-229
Epstein-Barr virus(EBV) has been implicated in the pathogenesis of B-lymphoproliferative disorders, T-cell lymphomas and Hodgkin's disease. In this report, we performed an in situ hybridization study on EBV genome in 10 cases of nasal non-Hodgkin's lymphoma(NHL), 20 cases of Waldeyer's ring(WR) NHL, and 20 cases of nodal NHLs to document EBV association with lymphomas in Koreans. For immunophenotyping, monoclonal antibodies for CD 20, MB 2, CD 45Ro & CD 43 were used. For in situ hybridization study, EBV DNA probe for Bam HI 'V' fragment and EBV RNA probe for EBER and BHLF were used. Twenty two cases(44%) of malignant lymphomas were positive for EBV genome. Generally, T-cell lymphomas showed a higher positive rate(61%) than B-cell lymphomas(24%). Among T-cell lymphomas, nasal lymphomas showed a higher positive rate(80%) than WR(50%) or nodal lymphomas(50%). Of 22 EBV genome positive cases, 10 cases were positive for EBER, 10 cases for BHLF, and 2 cases for both EBER and BHLF. The histologic types by Working Formulation(WF) were not correlated with EBV genome positive rate, whereas lymphomas showing the histologic spectrum of polymorphic reticulosis(PR) showed a higher positive rate(65%) than lymphomas without PR-like features(40%). These results indicate that nasal T-cell lymphomas with the histologic spectrum of PR are strongly associated with EBV and that the anatomic site may be an important factor in this association.
DNA, Viral/analysis
;
Genome, Viral
;
Herpesvirus 4, Human/*genetics
;
Human
;
*In Situ Hybridization
;
Lymphoma, Non-Hodgkin/*virology
;
RNA, Viral/analysis
7.Culture of HSV-2 and cloning of specific fragment of the gG-2 gene.
Jian GAO ; Yu-feng HUANG ; Jing CAO ; Hao-yang WANG ; Jin-chun LU
National Journal of Andrology 2009;15(3):223-227
OBJECTIVETo clone the glycoprotein G gene and its specific fragment with high conservation and antigenicity by culturing and amplifying herpes simplex virus type 2 and extracting its whole genome.
METHODSWe obtained a great deal of suspension with HSV-2 virus after infecting the cultured Hela cells with HSV-2 virus, extracted the whole genome of the virus by the phenol-chloroform method, and amplified the US4 gene coding gG-2 by PCR. Then we selected the specific target fragment according to the amino acid sequence alignment of the gG-2 gene and cloned it with the designed primers with restricted endonuclease sites.
RESULTSWe successfully obtained a lot of suspension with HSV-2 virus, and cloned the gG-2 gene from the whole genuine and its specific target fragment. Sequencing showed that both the sequences were identical with those printed in the GenBank.
CONCLUSIONIt is feasible to obtain the virus genome and specific fragment of the gG-2 gene from virus-infected cells, especially for HSV-2 virus with relatively stable hereditary trait. It has prepared the ground for further constructing the expression plasmid of the specific fragment, expressing related proteins and identifying their antigenicity.
Antigens, Viral ; genetics ; Cloning, Molecular ; DNA, Viral ; HeLa Cells ; Herpesvirus 2, Human ; genetics ; Humans ; Viral Envelope Proteins ; genetics ; Virus Cultivation
8.The construction and primary screening of a phage display library of HCV C and E1 genes evolved with an artificial pattern.
Fu-tao ZHAO ; Zhan-sheng JIA ; Jin-ge LI ; Chun-yu WANG ; Xin WEI ; Guang-yu LI ; Xue-fan BAI
Chinese Journal of Hepatology 2006;14(9):666-669
OBJECTIVESTo construct and screen a primarily phage display library of HCV C and E1 genes evolved with an artificial pattern.
METHODSTwo genes of about 1 kb with different genotypes were evolved by DNA shuffling. The re-assembled HCV C and E1 genes were cloned into a phage vector. After being rescued with helper phage M13KO7, a phage display library was constructed. Then the library was screened with anti-C and E1 McAb. Double-antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA) was carried out on twenty individual phage clones selected randomly to detect their binding and reactive activity with high-titer HCV-positive sera. Normal sera were used as controls.
RESULTSThe phage display library of HCV C and E1 genes which evolved with an artificial pattern was constructed. Their capacity amounted to 1.64 x 10(6), and 86 percent of the clones contained C and E1 genes. After four rounds of panning, the phage library was specifically enriched. Twelve positive clones were successfully screened.
CONCLUSIONThe capacity and diversity of the constructed library are enough for screening. The results demonstrate the superiority of the specific binding and reactive activity and affinity of the 12 phage clones from the HCV positive sera.
DNA, Viral ; genetics ; Gene Library ; Hepacivirus ; genetics ; Peptide Library ; Viral Core Proteins ; genetics ; Viral Envelope Proteins ; genetics
9.Analysis on the sequence mutation and evolution of HBV genome in China.
Yong Hao GUO ; Qiao Hua DOU ; Qian LIU ; Jian Hua YANG ; Yuan Yu LYU ; Da Xing FENG ; Ming Hua SENG ; Yan Yang ZHANG ; Dong Yang ZHAO
Chinese Journal of Epidemiology 2022;43(8):1309-1314
Objective: To understand immune escape mutation, drug resistance mutation, and genome evolution information of HBV genome sequence in China. Methods: The whole genome sequence information of HBV in China submitted in GenBank from 1998 to 2021 was selected as the object for analysis. MAFFT method was used for cluster analysis. Analysis of immune escape and drug-resistant mutations was performed using the online tool Gen2pheno. The BEAST 1.10.4 was used for analysis the time evolution of HBV sequences. Results: A total of 5 426 sequences were included in the dataset and distributed in 19 provinces of China. Type C accounted for the highest proportion (59.1%, 3 211/5 426), followed by type B (33.7%, 1 833/5 426). Immune escape mutations were found in 764 sequences (14.1%, 764/5 426). At least one reverse transcriptase region mutation occurred in 98.1% of the sequences. The evolutionary roots of most HBV sequences in China date from around 1801 AD. Conclusion: HBV-resistant mutation rate is high in China. HBV genomes evolve slowly.
China/epidemiology*
;
DNA, Viral/genetics*
;
Drug Resistance, Viral/genetics*
;
Genome, Viral
;
Genotype
;
Hepatitis B virus/genetics*
;
Humans
;
Mutation
10.Therapeutic Angiogenesis: The Pros and Cons and the Future.
Korean Circulation Journal 2008;38(2):73-79
Despite the improvements in medical, surgical and endovascular therapies, vascular disease is still a significant, critical clinical problem. The advances in understanding the mechanisms of neovascularization and the accumulated experiences of successful therapeutic application in animal models have raised expectations for therapeutic angiogenesis as a promising treatment option. However, the large, double-blinded, controlled clinical trials using therapeutic agent in the form of protein, naked DNA or viral gene therapy have failed to show clinical benefit. Nevertheless, by this time, cell based therapeutic angiogenesis has raised a promising option for the treatment of ischemic diseases. This article summarizes the essential preclinical research and major clinical trials on therapeutic angiogenesis, and it deals with several issues related to the failure of the clinical trials. Future directions in the realm of therapeutic angiogenesis are also described with focusing on cell based therapy.
DNA
;
Genes, Viral
;
Models, Animal
;
Tissue Therapy
;
Vascular Diseases